Currently out of the existing stock ratings of Bruce D. Jackson, 12 are a BUY (100%).

Bruce D. Jackson

Work Performance Price Targets & Ratings Chart

Analyst Bruce D. Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 25% that have a potential upside of 65.47% achieved within 332 days.

Bruce D. Jackson’s has documented 20 price targets and ratings displayed on 2 stocks.

Most recent stock forecast was given on UNCY, Unicycive Therapeutics at 20-Aug-2026.

Wall Street Analyst Bruce D. Jackson

Analyst best performing recommendations are on UNCY (UNICYCIVE THERAPEUTICS).
The best stock recommendation documented was for UNCY (UNICYCIVE THERAPEUTICS) at 8/17/2021. The price target of $13 was fulfilled within 183 days with a profit of $12.6 (49.22%) receiving and performance score of 2.69.

Average potential price target upside

UNCY Unicycive Therapeutics HUMA Humacyte

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Oct-2025

$13

$9.64 (286.90%)

$15

24 days ago
(29-Sep-2026)

0/4 (0%)

$8.45 (185.71%)

Buy Since 17-Aug-2021

$15

$10.2 (212.50%)

$13

2 months 3 days ago
(20-Aug-2026)

2/8 (25%)

$9.55 (175.23%)

332

Buy Since 17-Aug-2021

$15

$11.64 (346.43%)

$13

2 months 3 days ago
(20-Aug-2026)

0/11 (0%)

$9.55 (175.23%)

Buy Since 30-Jun-2026

$20

$16.64 (495.24%)

$22

2 months 10 days ago
(13-Aug-2026)

0/2 (0%)

$14.6 (270.37%)

Buy Since 29-Dec-2025

$25

$21.64 (644.05%)

$37

2 months 10 days ago
(13-Aug-2026)

0/4 (0%)

$19.6 (362.96%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Bruce D. Jackson most bullish on?

Potential upside of $10.2 has been obtained for UNCY (UNICYCIVE THERAPEUTICS)

What Year was the first public recommendation made by Bruce D. Jackson?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?